Upregulation of integrin adhesive receptors has been implicated in various pathological conditions. We examined expression and function of integrin adhesive receptors on peripheral blood lymphocytes from patients with systemic lupus erythematosus (SLE), particularly those with the complication of vasculitis, and found that VLA4 and LFA-1 expression was increased in SLE patients with vasculitis, while LFA-1 but not VLA-4 expression was increased in those without vasculitis. These results suggested a role of VLA4 in the pathogenesis of vasculitis in SLE. Functional studies further demonstrated that adhesion to cytokine-activated human umbilical cord vein endothelial cells and to the CS-1 alternatively spliced domain of fibronectin was significantly increased in SLE patients with vasculitis. Analysis of the functional epitopes on the a4 chain demonstrated that antigen densities of all the functional epitopes were increased in those with vasculitis, indicating that the increased expression of VLA4 resulted from the increased number of VLA4 molecules, and was not secondary to an increase in one particular functional epitope. Immunoprecipitation studies further support these results. Interestingly, high molecular weight bands associated with VLA4 were observed in about half of the SLE patients with vasculitis. These results introduce a possibility that upregulation of integrin adhesive receptors has a potential role in the pathogenesis of vasculitis in SLE. (J. Clin. Invest. 1993.92:3008-3016.)
Introduction
Systemic lupus erythematosus (SLE) is a multi-system disorder characterized by the production of a variety of autoantibodies ( 1 ). Some autoantibodies are pathogenic (2) and cause tissue damage by directly reacting with the surface of platelets and erythrocytes (3), or by forming immune complexes upon 1 . Abbreviations used in this paper: ECM, extracellular matrix; HU-VEC, human umbilical cord vein endothelial cell; KLH, keyhole limpet hemocyanin; MFR, mean fluorescence intensity. activation of complement (4) . Anti-DNA and DNA immune complexes have been eluted from the affected kidneys in SLE patients (5) , and can cause lupus glomerulonephritis, indicating that immune complex-mediated tissue injuries are of central importance in the pathogenesis of lupus nephritis. This is the best understood scenario for the pathogenesis of SLE. Although the deposition of immune complexes in the tissue has been implicated in the pathogenesis ofSLE, it is still possible to assume additional and alternative mechanisms for the tissue injuries in the disease. In this regard, immunopathological findings by Savage (6) showed that immune complexes can rarely be found in the blood vessels from biopsy specimens of SLE patients with vasculitis.
Recently, Phillip et al. suggested that an alternative mechanism of vascular damage may occur in SLE involving intravascular activation and aggregation of neutrophils in the absence ofimmune complex deposition (7) . They introduced the possibility that the Schwartzman reaction is a model of this type of vascular injury, and that it is not mediated by immune complex deposition. Cytokine-primed neutrophil-dependent vascular damage has thus been demonstrated to participate in a rabbit model of hemorrhagic vasculitis in the absence of immune complex deposition (8) . Ifthis is the case for the mechanism of tissue injury in SLE, interaction between leukocytes and endothelium or substitium in connective tissues may have a major role in pathogenesis of the disease.
Recent progress in the study of adhesion molecules has revealed that several sets of surface molecules participate in cellcell and cell-substitium adhesions (9) . Members ofthe # I integrin family of adhesion molecules, which comprises nine different a chains and a noncovalently associated # 1 subunit, are major adhesive receptors for the extracellular matrix (ECM)' proteins ( 10) . On the other hand, the (32 integrin family mediates cell-cell adhesion. In the (31 integrin subfamily, VLA-4, and now VLA-3, are exceptionally involved in both cell-cell and cell-ECM adhesion. The function and expression of these adhesive receptors are properly regulated (9-1 1 ). Upregulation ofthese adhesive receptors has been found in several pathological conditions such as atherosclerosis ( 12) , and bronchial asthma, as well as in the synovial T cells ofrheumatoid arthritis ( 13 ) . We also experienced a case ofSLE complicated by necrotizing vasculitis ofthe mesenteric artery, which resulted in perforation of the ileum. In this particular patient, the expression and function of VLA-4 was increased during the vasculitic event, indicating a role ofthe integrin adhesive receptors in the pathogenesis of vasculitis in SLE.2 A similar idea came from the following studies in which we conducted a series of experiments to identify the surface structures important for the pathogenesis of SLE, and attempted to develop mAbs directed against the surface antigen on lymphocytes from SLE patients on the basis of increased reactivity with the patients' lymphocytes compared to normal individuals. Among those mAbs, we found that a clone, SM-27, recognizing the surface antigen whose expression on SLE lymphocytes was greater than normal lymphocytes, identifies the VLA-4 antigen ( 14) .
These studies, however, were performed only in a case of SLE complicated by vasculitis, and there has not yet been a determination of the expression and function of integrin adhesive receptors in substantial numbers of SLE patients with vasculitis to permit us to draw some conclusions.
In this study we attempted to delineate the expression and function of these adhesive receptors of the integrin family on peripheral blood lymphocytes in patients with SLE. We demonstrated that expression and function ofVLA-4 as well as LFA- 1 were upregulated in SLE patients with vasculitis, while LFA-1 but not VLA-4 expression was increased in SLE patients without vasculitis. Moreover, the function of VLA-4 in terms of adhesiveness to fibronectin and cytokine-activated endothelial cells is increased in these patients. Immunoprecipitation studies showing increased 140-, 80-, and 70-kD bands ofthe VLA-4 a chain in patients with vasculitis confirmed the above results. Surprisingly, we also found that 1 80-kD extra-bands were observed by immunoprecipitation of VLA-4 from peripheral blood lymphocytes of the vasculitis patients. These results introduce a possible role of integrin adhesive receptors in the pathogenesis of vasculitis in SLE.
Methods
Patients. The sample population consisted of 27 patients with SLE satisfying the classification criteria proposed by the American Rheumatism Association ( 15). Disease activity was determined for each patient at the time of blood drawing by two physicians on the basis of multi-system disease manifestations, as described previously (16 Immunofluorescence analysis. Cells were incubated with mAbs for 30 min on ice, then incubated with a F(ab')2 fragment of goat antimouse antibody conjugated with FITC (Tago, Inc., Burlingame, CA) as described previously (16) .
The flow cytometer (Becton Dickinson Immunocytometry Systems) was run on fixed laser power (600 mW at 488 nm) over the period of the study. Flow cytometric standardization was achieved by running 4.05-im fluorescent beads (Becton Dickinson Immunocytometry Systems), which exhibited constant light scatter and fluorescence properties. Background fluorescence reactivity was determined with control ascitic fluid obtained from mice immunized with a nonsecreting hybridoma. Control and patient samples were run with the FITC photomultiplier adjusted to a high enough voltage such that the fluorescence histogram derived from the forward angle vs. side scattergated lymphocyte population yielded 2-7% background autofluorescence intensity in the range reserved for positively FITC-stained cells. All samples were, then, analyzed using the fixed photomultiplier setting. For each sample, 10,000 cells were analyzed on a log fluorescence scale on the flow cytometer. For determination of the surface antigen expression, the mean log FITC-fluorescence channel of the positivelystained cells was determined from a single-parameter histogram.
Isolation ofcells. PBL from normal individuals and patients with SLE were separated from heparinized venous blood by Ficoll-Hypaque density gradient centrifugation (Pharmacia LKB Biotechnology, Uppsala, Sweden) as described previously (16) . PBL were suspended in medium containing 10% FCS (Hazelton Biologics, Inc., Lenexa, KS) and were incubated on 1% serum-coated dishes, and passed over a nylon-wool column to yield a T cell-enriched population. This T cell population was more than 92% reactive with anti-T3 antibody.
ECMproteins and theirfragments. Fibronectin, laminin, and collagen types I, II, III, IV were purchased from Sigma Chemical Co. (St. Louis, MO). Oligopeptides corresponding to the VLA-4-binding site of fibronectin were synthesized by an amino acid synthesizer (Biolynx Peptide Synthesizer; Pharmacia LKB Biotechnology), then purified with an FPLA system with a mono-Q column. The oligopeptides GPEILDVPST (CS-lA) and TLPHPNLHGP (CS-1B) were conjugated to keyhole limpet hemocyanin (KLH) by the maleimid method as described in the manufacture's brochure (Pierce Chemical Co., Rockford, IL).
Assays ofcell attachment to ECM proteins and HUVECs. For cell attachment to ECM proteins, flat-bottomed 96-well microtiter plates (Costar Corp., Cambridge, MA) were coated with 100 y1 of 0.1 M NaHCO3 containing 10 ,ug of fibronectin, laminin, collagen, CS-1A, and CS-I B oligopeptides for 2 h at 37°C and then coating was blocked with RPMI 1640 medium in the presence of 1% BSA (Sigma Chemical Co.) for 1 h at 37°C. Cell surface labeling and immunoprecipitation. Cells were surface labeled with sulfo-NHS-biotin (Pierce Chemical Co.) as described in the manufacture's brochure, and lysed in the presence of 1% NP-40 as described previously (17) . Cell lysates were precleared with insoluble protein A (Sigma Chemical Co.), and incubated with mAbs. The immune complexes were precipitated with protein G-agarose beads (Pharmacia LKB Biotechnology), and washed five times with lysis buffer. Sample buffer was added, and the mixture was boiled for 5 min. The samples were run on 6% polyacrylamide gels. After electrophoresis, the gels were equilibrated for 10 min in a transfer buffer (25 mM Tris-HCl, 192 mM glycine, and 20% methanol) and proteins were electrophoretically blotted onto polyvinylidene difluoride membranes (Millipore Corp., Bedford, MA). The membranes were soaked at 37°C for 1 h in blocking agents (Blockace; Dainippon Pharmaceuticals, Tokyo), and streptoavidin-horseradish peroxidase conjugate (Amersham International, Amersham, UK) was added at a dilution of 1:1,000 with PBS containing 0.1% Tween-20 and 10% Blockace. After incubation at 37°C for 1 h, the membranes were washed three times and the detection of the horseradish peroxidase-labeled proteins was carried out with chemiluminescence-enhancing reagents as described in the manufacture's brochure (Amersham International). The treated membranes were visualized on ECL x-ray films.
Results
Expression ofintegrin adhesive receptors in SLE. To delineate a role ofintegrin adhesive receptors in the pathogenesis of SLE with vasculitis, we examined expression ofintegrins on PBL in SLE patients with vasculitis, those without vasculitis, and normal individuals. The age, sex, disease activity, disease type, disease duration, clinical manifestations of the vasculitis, and dose of prednisolone in SLE patients studied are summarized in Table I . The mean age and sex were comparable between the SLE patients and normal individuals. All patients without vasculitis had active disease, except for two, while all six patients with vasculitis were judged to be active. Disease type and disease duration were comparable between SLE patients without and with vasculitis. The dose of prednisolone was not statistically significant between these two populations of SLE.
The representative cytofluorographic pattern in Fig. 1 shows that CD29, CDl la, and CD18 antigens have a bimodal distribution in fluorescence intensity on a log scale, indicating that there are two distinct fractions expressing high or low levels ofCD29, CD I I a, and CD 18. Therefore, the percent expression and mean fluorescence intensity (MFI) of the population expressing high levels of antigens are shown as CD29 high, CDl la high, and CD18 high. As seen in Table II , there are no significant changes in percent expression of CD3, VLA-1, VLA-2, VLA-3, VLA-4, VLA-5, and VLA-6, whereas the percent expression of the CD29 high population was increased in the SLE patients with vasculitis, supporting the previous observation. With respect to ,32 integrins, the percent expressions of CD I la high, CD 1 I c, and CD 18 high are significantly higher in the vasculitis patients than in normal individuals (56±29%, 45±6%, and 57±29%, respectively), while CD1 la high and CD 18 high are also increased in the SLE patients without vasculitis (49±18%, and 47±19%, respectively). When we determined the antigen densities by comparing the MFI of the surface antigens, that ofVLA-4 a was significantly increased in the SLE patients with vasculitis, compared to normal individuals ( 101±56, and 61±22, respectively), whereas no significant increase was observed in the SLE patients without vasculitis. Similarly, the MFI of CD I I a as well as CD 1 8 was increased in the vasculitis patients. These results clearly indicate that expression of VLA-4 and LFA-1 antigens was upregulated in the vasculitis patients. It is well accepted that after activation it is the CD4+ T cells that express adhesion molecules such as CD29, Adherence of T cells to cytokine-activated HUVECs in SLE. The above results clearly show that the integrin adhesive receptors were upregulated on the PBL as well as on CD4+ T cells from SLE patients with vasculitis. Next, we attempted to determine the function of these adhesive receptors. First, we studied adhesion to endothelial cells, since this process should be of primary importance for eliciting vascular inflammation (9, 19) . Through the use of IL-1,-and TNFa-stimulated HUVECs, which have already been shown to express ICAM-1 and VCAM-1 antigens (20) , the ligands for LFA-1 and VLA-4, respectively, adhesion of peripheral blood T cells from normal individuals, and patients without, or with vasculitis, was examined. As shown in Fig. 2 , T cells from patients with vasculitis showed a significant increase in adhesion to cytokine-activated endothelial cells ( 189±47), whereas T cells from patients without vasculitis showed a slight but significant increase in adhe- Clinical course ofthe representativepatients and the expression and function of integrin adhesive receptors. We found upregulated expression and function of these integrin adhesive receptors in the SLE patient with vasculitis. The next question is whether such alteration of the integrin receptors may be correlated with the clinical course of the disease. To address this question, we examined for expression of integrin adhesive receptors on the PBL from patients with vasculitis whom we could follow up on serially. As shown in the left panel of the MFI of VLA-4 (closed circle) was significantly elevated in patient F.S. Soon after that, she experienced digital necrosis of the left fourth finger and was admitted to the hospital. She was successfully treated with increased doses of prednisolone and surgical debridement of the necrotic finger, and expression of VLA-4 returned to within normal limits. Also in patient Y.K., expression ofVLA-4 and the percentage ofthe CD29 high population (open circles) were increased when she experienced a digital infarct due to necrotizing vasculitis, whereas expression of these molecules returned to normal in July 1992. However, when digital necrosis recurred shortly after that, the MFI ofthe VLA-4 antigen increased again. Although the sample size is rather small and we may have to wait to draw definitive conclusions from these two cases, the correlation of upregulated expression of VLA-4 antigen and the vasculitic events observed here further support the idea that such adhesive receptors may participate in the pathogenesis of vasculitis in patients with SLE.
Functional epitopes ofthe VLA-4 antigen in SLE patients with vasculitis. The above results suggest that upregulated expression and function of VLA-4 occurs on PBL from the SLE patients with vasculitis, and it has been reported that there are three distinct and independently inhibitable functional epitopes on VLA-4 molecules (22) . Since the increased expression of VLA-4 obtained in the above study was derived from MFI by SM-27, it remains to be determined whether epitopes other than that recognized by SM-27 are upregulated or not. To test this, we used a series of anti-VLA-4 mAbs and examined PBL from the vasculitis patients for expression of the distinct functional epitopes. Since SM-27 could block the aggregation induced by L-25 defining the B2 epitope, adhesion to CS-I 92'11 93'2
Vasculitis and date These results suggest that the increase in MFI of VLA-4 antigen did not result from an increase of one particular functional epitope but was due to an increase in the number of VLA-4 molecules expressed on PBL.
Structure ofthe VLA-4 antigen in SLE patients with vasculitis. To further examine the structural basis of VLA-4 molecules expressed on PBL, we carried out an immunoprecipitation analysis ofthe VLA-4 antigen on PBL from these patients. As seen in Fig. 7 , we clearly showed 140-kD bands corresponding to the intact a4 chain of VLA-4 antigen as well as 80-and 70-kD fragments, from normal individuals, the SLE patients without vasculitis and those with vasculitis. The 80-and 70-kD bands had more intense signals in the patients with vasculitis than those of normal individuals and the patients without vasculitis, supporting the above observations that the number of VLA-4 molecules expressed on PBL in the SLE patients with vasculitis was greater than those ofnormal individuals and SLE patients without vasculitis. Surprisingly, we observed an extra band migrating around 180 kD along with the 80-, 70-, and 140-kD a4 bands in three of the six patients with vasculitis.
Discussion
In this study, we demonstrated upregulation in expression and function of, 1 as well as fl2 integrins on PBL from SLE patients with vasculitis. More specifically, expression of VLA-4 and LFA-1 was significantly greater in patients with vasculitis than in normal individuals, but LFA-1 was also upregulated in SLE patients without vasculitis. Function in terms of adhesiveness to cytokine-activated endothelial cells and the CS-1 domain of fibronectin was enhanced in SLE patients with vasculitis. Moreover, among those patients with upregulation of integrin adhesive receptors, half of the patients with vasculitis had the high molecular mass form (1 80-kD) of VLA-4.
It is well accepted that CD4+ T cells are distinguished by their differential expression of isoforms of CD45, namely CD45RA and CD45RO, with distinct functions (23) (24) (25) . In addition, it has been shown that expression ofthe 131 and of a4, Figure 6 . MFI of functional epitopes on the VLA-4 alpha chain recognized by various anti-VLA-4 antibodies expressed on PBL from sex-and age-matched normal individuals (black bar; n = 27), SLE patients without vasculitis (gray bar; n = 21), and those with vasculitis (shaded bar; n = 6) was shown. *P < 0.05. a5, and a6 on the CD45RO subset of CD4+ T cells is several times higher than on the CD45RA subset of CD4+ T cells (1 1,  21 ). Similar observations were reported for expression of 32 integrins (9, 18) . These findings suggest that the subsets of CD4+ T cells may represent two stages ofT cell differentiation, memory and naive (26) (27) (28) . The present study showing the decreased percentage ofCD4+CD45RA+ cells in SLE patients both with and without vasculitis supports the previous observations ( 16, 23) . One may wonder whether the increased expression of these adhesion molecules could be the result of accelerated conversion from CD45RA to CD45RO in these vasculitic patients. However, the increased expression of VLA-4 antigen was observed only in the patients with vasculitis, not in the patients without vasculitis, while both kinds of patients had a (6) . It has been suggested that an alternative mechanism such as the Schwartzman reaction, but not the Arthus reaction, participates in the pathogenesis of vasculitis (7) . In this model, intravascular LFA-I /ICAM-1 (leukocyteendothelium) adhesion was shown to be necessary for this type of cytokine-primed, neutrophil-dependent vasculitis to occur (8) . Given the evidence that VLA-4 mediates homotypic aggregation of lymphocytes, and adhesion of lymphocytes to endothelial cells via VCAM-1 molecules as well as to the alternatively spliced domain of fibronectin (21, 39, 40) , the upregulated function of VLA-4 in addition to that of LFA-1 could be the mechanisms responsible for the development ofthe characteristic pathological features ofvasculitis in SLE. Furthermore, as suggested in the RA synovial T lymphocytes ( 13, 29, 41 ), VLA-4/VCAM-1 and LFA-1 /ICAM-1 pathways not only mediate adhesion ofleukocyte-leukocyte and leukocyte-endothelium, but by delivering signals into the cells to proliferate by interacting with their ligands could be important mechanisms for the infiltration of the inflammatory cells into the vessel walls and interstitium, and the maintenance of these cells to perpetuate the vascular inflammation.
The present study provides the first evidence that expression and function of VLA-4 antigen was upregulated in SLE patients with vasculitis, introducing a potential role of antigen in the pathogenesis of vasculitis in SLE. At present, however, it is not clear whether the upregulated expression of integrins is the consequence of the vasculitis events or is directly involved in the pathogenesis. To address the issue, it may be useful to examine the effect of anti-VLA-4 antibody in model animals for vasculitis. It has been reported that induction of adjuvant arthritis in Lewis rats could be successfully inhibited by anti-ICAM-1 antibody (42) and rat cardiac allograft survival was extended by administration of anti-ICAM- 1 and/or anti-LFA-1 antibody in heterotropic rat cardiac transplantation (43) . If it is the case in model animals for vasculitis by anti-VLA-4 antibody, the intervention with the pathway in addition to LFA-l /ICAM-l interaction may contribute to developing a new and ideal therapeutic strategy for the intractability and sometimes fatality of SLE caused by vasculitis.
